Tirilazad: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|An article about the drug Tirilazad}} | |||
{{Drugbox | |||
| verifiedfields = changed | |||
| verifiedrevid = 477002123 | |||
| image = Tirilazad.svg | |||
| image_size = 200px | |||
| image_alt = Chemical structure of Tirilazad | |||
}} | |||
'''Tirilazad''' is a synthetic steroid derivative that acts as a potent inhibitor of lipid peroxidation. It is primarily investigated for its neuroprotective properties in the treatment of acute neurological injuries such as [[subarachnoid hemorrhage]] and [[spinal cord injury]]. | |||
Tirilazad | ==Mechanism of Action== | ||
Tirilazad functions by inhibiting the peroxidation of lipids in cell membranes, a process that can lead to cell damage and death. This is particularly important in the context of [[central nervous system]] injuries, where oxidative stress plays a significant role in secondary injury mechanisms. By reducing lipid peroxidation, Tirilazad helps to preserve cellular integrity and function. | |||
== | ==Clinical Applications== | ||
Tirilazad has been studied in various clinical settings, particularly in the management of subarachnoid hemorrhage and spinal cord injury. In these conditions, the drug is thought to mitigate the effects of oxidative stress and inflammation, potentially improving neurological outcomes. | |||
Tirilazad | ===Subarachnoid Hemorrhage=== | ||
In patients with subarachnoid hemorrhage, Tirilazad has been evaluated for its ability to reduce the incidence of [[vasospasm]], a common and serious complication. While early studies showed promise, subsequent trials have yielded mixed results, and its use in this context remains controversial. | |||
== | ===Spinal Cord Injury=== | ||
Tirilazad has also been investigated for its potential to improve outcomes following spinal cord injury. The drug's ability to limit oxidative damage and inflammation is thought to contribute to neuroprotection and functional recovery. | |||
==Pharmacokinetics== | |||
Tirilazad is administered intravenously, and its pharmacokinetic profile is characterized by rapid distribution and metabolism. The drug is metabolized primarily in the liver and excreted in the urine. Its half-life and clearance rates can vary depending on the patient's condition and other factors. | |||
== | ==Side Effects== | ||
The use of Tirilazad can be associated with several side effects, including [[gastrointestinal]] disturbances, [[hypotension]], and [[allergic reactions]]. Careful monitoring is required to manage these potential adverse effects. | |||
==Research and Development== | |||
Despite initial enthusiasm, the development of Tirilazad has faced challenges due to inconsistent clinical trial results. Research continues to explore its potential benefits and limitations in various neurological conditions. | |||
== | ==Related pages== | ||
* [[Neuroprotection]] | |||
* [[ | * [[Oxidative stress]] | ||
* [[ | |||
* [[Lipid peroxidation]] | * [[Lipid peroxidation]] | ||
* [[ | * [[Subarachnoid hemorrhage]] | ||
* [[Spinal cord injury]] | |||
[[Category: | [[Category:Neuroprotective agents]] | ||
[[Category: | [[Category:Steroids]] | ||
Revision as of 03:39, 13 February 2025
An article about the drug Tirilazad
| Tirilazad | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Tirilazad is a synthetic steroid derivative that acts as a potent inhibitor of lipid peroxidation. It is primarily investigated for its neuroprotective properties in the treatment of acute neurological injuries such as subarachnoid hemorrhage and spinal cord injury.
Mechanism of Action
Tirilazad functions by inhibiting the peroxidation of lipids in cell membranes, a process that can lead to cell damage and death. This is particularly important in the context of central nervous system injuries, where oxidative stress plays a significant role in secondary injury mechanisms. By reducing lipid peroxidation, Tirilazad helps to preserve cellular integrity and function.
Clinical Applications
Tirilazad has been studied in various clinical settings, particularly in the management of subarachnoid hemorrhage and spinal cord injury. In these conditions, the drug is thought to mitigate the effects of oxidative stress and inflammation, potentially improving neurological outcomes.
Subarachnoid Hemorrhage
In patients with subarachnoid hemorrhage, Tirilazad has been evaluated for its ability to reduce the incidence of vasospasm, a common and serious complication. While early studies showed promise, subsequent trials have yielded mixed results, and its use in this context remains controversial.
Spinal Cord Injury
Tirilazad has also been investigated for its potential to improve outcomes following spinal cord injury. The drug's ability to limit oxidative damage and inflammation is thought to contribute to neuroprotection and functional recovery.
Pharmacokinetics
Tirilazad is administered intravenously, and its pharmacokinetic profile is characterized by rapid distribution and metabolism. The drug is metabolized primarily in the liver and excreted in the urine. Its half-life and clearance rates can vary depending on the patient's condition and other factors.
Side Effects
The use of Tirilazad can be associated with several side effects, including gastrointestinal disturbances, hypotension, and allergic reactions. Careful monitoring is required to manage these potential adverse effects.
Research and Development
Despite initial enthusiasm, the development of Tirilazad has faced challenges due to inconsistent clinical trial results. Research continues to explore its potential benefits and limitations in various neurological conditions.
